Conditions: Alzheimer's Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 641
Healthy volunteers: no

Brief summary:
This study is designed to determine the effectiveness of florbetapir (18F) in changing patient management and to evaluate the association between scan status and cognitive decline.

Detailed description:

Arms:
arm 1: Subjects will receive florbetapir (18F) PET scans and physicians will have immediate access to PET scan results. arm 2: Subjects will receive florbetapir (18F) PET scans but physicians will be blinded to PET scan results for 12 months

Interventions: intervention 1: florbetapir (18F)
Intervention descriptions: intervention 1: Single i.v. bolus injection of 370MBq (10 mCi) followed by saline flush, 50 minutes prior to imaging, 10 minute image duration

Protocol document: